UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
SBFM holding history
Sunshine Biopharma Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SBFM overviewAll 13F holders of SBFMFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,103−100.0% | Sold out | Holders |
| Q1 2026 | 1,103 | $1.15K | <0.1% | −770−41.1% | Reduced | Holders |
| Q4 2025 | 1,873 | $2.30K | <0.1% | +1,667+809.2% | Added | Holders |
| Q3 2025 | 206 | $307 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 206 | $297 | <0.1% | −19,679−99.0% | Reduced | Holders |
| Q1 2025 | 19,885 | $38.0K | <0.1% | +19,017+2,190.9% | Added | Holders |
| Q4 2024 | 868 | $2.60K | <0.1% | +868 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −1−100.0% | Sold out | Holders |
| Q2 2024 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1 | $0 | 0.0% | −2,200−100.0% | Reduced | Holders |
| Q4 2023 | 2,201 | $598 | <0.1% | +2,200+220,000.0% | Added | Holders |
| Q3 2023 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1 | $0 | 0.0% | −2,406−100.0% | Reduced | Holders |
| Q1 2023 | 2,407 | $1.76K | <0.1% | −4,803−66.6% | Reduced | Holders |
| Q4 2022 | 7,210 | $4.62K | <0.1% | +7,209+720,900.0% | Added | Holders |
| Q3 2022 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1 | $0 | 0.0% | −2,433−100.0% | Reduced | Holders |
| Q1 2022 | 2,434 | $6.00K | <0.1% | +2,434 | New | Holders |